Abstract
Summary The racemic mixture and the (−)enantiomer of the putative dopamine autoreceptor agonist 3-PPP were investigatedin vitro using dopaminesensitive adenylate cyclase in homogenates of rat striatum as a model for a postsynaptic D1-receptor type and inhibition of electrically-evoked tritium overflow from rat striatal slices preincubated with [3H]choline and [3H] dopamine as a model for a postsynaptic D2- and a presynaptic dopamine autoreceptor type, respectively. In contrast, to apomorphine, neither the racemic mixture nor the (−)enantiomer exerted any effect, suggesting agonistic properties in all three receptor models. However, both (±)3-PPP and (−)3-PPP were weak antagonists at postsynaptic D1- and D2-receptors. The results of the present investigation suggest that thein vivo effects of 3-PPP are either the result of metabolic activation or that this drug activates an other dopamine autoreceptor type, pharmacologically different from that one modulating doopamine release.

This publication has 17 references indexed in Scilit: